Exciva GmbH has raised €51 million ($59m) in a Series [...]

Amorphical has announced positive final long-term results from its Phase [...]

  AC Immune SA has reported positive interim results from [...]

Kairos Pharma, Ltd. will present positive safety and early efficacy [...]

Kairos Pharma has announced encouraging interim efficacy results from its [...]

Servier has acquired KER-0193 from Kaerus Bioscience, gaining a potential [...]

Gesynta Pharma has announced the second closing of its Series [...]

DiaMedica Therapeutics Inc has announced positive interim results from Part [...]

Data presented at ISTH 2025 highlight potential for improved outcomes [...]